https://doi.org/10.1016/s1470-2045(19)30804-6
J
Joyce Cheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
1.6K
Citations
18
h-index
21
i10-index
Joyce Cheng is an academic researcher from United States Food and Drug Administration. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Breast Cancer Treatment Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 18, co-authored 48 publications.
ORCID: 0009-0006-0630-9844Papers by this author
worksCDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
2019 · The Lancet Oncology · 290 citations
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, <i>HER2</i> -Positive <i>RAS</i> Wild-Type Colorectal Cancer
2023 · Clinical Cancer Research · 35 citations
https://doi.org/10.1158/1078-0432.ccr-23-1041
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer
2025 · Clinical Cancer Research · 7 citations
https://doi.org/10.1158/1078-0432.ccr-25-1388
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Locally Advanced or Metastatic Breast Cancer
2025 · Journal of Clinical Oncology · 3 citations
https://doi.org/10.1200/jco-25-00663
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting
2025 · Journal of Clinical Oncology · 1 citations
https://doi.org/10.1200/jco-25-00167
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat